Xueqiong Wu

china national petroleum corporation

H指数:24

被引数:2,125

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dysregulation of the JNK signaling pathway in tuberculosis: mechanisms and therapeutic strategies

结核病中JNK信号通路的失调：机制与治疗策略

Frontiers in Cellular and Infection Microbiology

IF4.8

2025-11-260

OAAI

Triassic-Jurassic Hydrocarbon Source Rock Comparison in the Northern Kuqa Depression, Tarim Basin: Geochemical Characteristics and Hydrocarbon Potential

APPLIED GEOPHYSICS

IF0.8

2025-10-010

PRE

Experimental validation of cuproptosis-associated molecular signatures and their immunological implications in pulmonary tuberculosis

铜死亡相关分子特征及其在肺结核中免疫学意义的实验验证

Frontiers in Immunology

IF5.9

2025-07-300

Evaluation of Immunogenicity of Mycobacterium tuberculosis ag85ab DNA Vaccine Delivered by Pulmonary Administration

通过肺途径给药的Mycobacterium tuberculosis ag85ab DNA疫苗免疫原性的评估

VACCINES

IF3.4

2025-04-230

Bioinformatics analysis, immunogenicity, and therapeutic efficacy evaluation of a novel multi-stage, multi-epitope DNA vaccine for tuberculosis

生物信息学分析、免疫原性及对一种新型多阶段、多表位结核病DNA疫苗的治疗效果评估

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2025-04-010

OAAI

Bioinformatics Analysis and Immunogenicity Assessment of the Novel Multi-Stage DNA Vaccine W541 Against Mycobacterium Tuberculosis

新型结核分枝杆菌多阶段DNA疫苗W541的生物信息学分析及免疫原性评价

IMMUNITY INFLAMMATION AND DISEASE

IF2.7

2024-11-260

OAAI

The advances in adjuvant therapy for tuberculosis with immunoregulatory compounds

FRONTIERS IN MICROBIOLOGY

IF4.5

2024-06-203

OAAI

The changes and its significance of peripheral blood NK cells in patients with tuberculous meningitis

FRONTIERS IN MICROBIOLOGY

IF4.5

2024-02-292

OAAI

Exploring BCG vaccination as a novel approach to prevent recurrent herpes labialis

ECLINICALMEDICINE

IF10

2023-11-012

OAAI

Mechanisms of ag85a/b DNA vaccine conferred immunotherapy and recovery from Mycobacterium tuberculosis-induced injury

IMMUNITY INFLAMMATION AND DISEASE

IF2.7

2023-05-165

OAAI

Preventive effects of Mycobacterium tuberculosis DNA vaccines on the mouse model with latent tuberculosis infection

结核分枝杆菌DNA疫苗对结核潜伏感染小鼠模型的预防作用

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-02-134

OAAI

Prediction of Th1 and Cytotoxic T Lymphocyte Epitopes of Mycobacterium tuberculosis and Evaluation of Their Potential in the Diagnosis of Tuberculosis in a Mouse Model and in Humans

结核分枝杆菌Th1和细胞毒性T淋巴细胞表位的预测及其在小鼠模型和人类结核病诊断中的潜力评估

MICROBIOLOGY SPECTRUM

IF3.8

2022-08-3110

OAAI

Immunotherapeutic Effects of Different Doses of Mycobacterium tuberculosis ag85a/b DNA Vaccine Delivered by Electroporation

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-05-0411

OAAI

Peptide-Based Vaccines for Tuberculosis

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-01-3165

OAAI

Differential Diagnosis of Latent Tuberculosis Infection and Active Tuberculosis: A Key to a Successful Tuberculosis Control Strategy

FRONTIERS IN MICROBIOLOGY

IF4.5

2021-10-2297

OAAI

COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials

新型冠状病毒肺炎大流行: SARS-CoV-2特定疫苗和挑战，通过BCG训练免疫保护和临床试验

EXPERT REVIEW OF VACCINES

IF4.8

2021-06-1538

OAAI

Comparative study on the antituberculous effect and mechanism of the traditional Chinese medicines NiuBeiXiaoHe extract and JieHeWan

中药牛贝消合提取物与解河丸抗结核作用及机制的比较研究

MILITARY MEDICAL RESEARCH

IF22.9

2021-06-026

OAAI

Prediction and analyses of HLA-II restricted Mycobacterium tuberculosis CD4+ T cell epitopes in the Chinese population

BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY

IF2.7

2021-05-043

PREAI

Peptides-Based Vaccine MP3RT Induced Protective Immunity Against Mycobacterium Tuberculosis Infection in a Humanized Mouse Model

基于肽的疫苗MP3RT在人源化小鼠模型中诱导针对结核分枝杆菌感染的保护性免疫

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-04-2646

OAAI

Chinese Traditional Medicine NiuBeiXiaoHe (NBXH) Extracts Have the Function of Antituberculosis and Immune Recovery in BALB/c Mice

JOURNAL OF IMMUNOLOGY RESEARCH

IF3.6

2021-01-184

OAAI

Xueqiong Wu

个人简介

教育背景

工作经历

荣誉奖项

研究方向